Avadel Pharmaceuticals PLC (STU:AWK)
€ 9.85 0.4 (4.23%) Market Cap: 949.15 Mil Enterprise Value: 888.38 Mil PE Ratio: 0 PB Ratio: 13.32 GF Score: 40/100

Avadel Pharmaceuticals PLC at Jefferies Healthcare Conference (Virtual) Transcript

Jun 04, 2020 / 02:00PM GMT
Release Date Price: €6.8 (-1.45%)
Chris Howerton
Jefferies LLC - Analyst

Hi, good morning, everybody. This is Chris Howerton from the Jefferies biotechnology equity research team. Thank you so much for joining us for 2020 Virtual Healthcare Conference. So pleased to be joined by the next company, Avadel Pharmaceuticals.

And on behalf of the team is the -- on behalf of the Company is the management team represented by Greg Divis, the CEO; Tom McHugh, the CFO; and Jordan Dubow is there but we can't quite see him right now. So, thanks for joining me, gentlemen.

Greg Divis
Avadel Pharmaceuticals plc - CEO

Thanks, Chris. We appreciate the opportunity to join the conference and the opportunity to talk more about Avadel and in particular FT218.

Chris Howerton
Jefferies LLC - Analyst

Awesome. Okay, well let's get into it then. So, maybe for those of us that aren't totally familiar with your story, what is FT218 and where are we with its development?

Greg Divis
Avadel Pharmaceuticals plc - CEO

Yes,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot